News

The transaction includes a 10-year contract for Express Scripts to provide services to WellPoint following closing of the transaction. The transition to Express Scripts’s platform and products will

Successful completion of this offer, assuming full acceptance, would raise the indirect stake of Pfizer Inc in Pfizer Limited to 75% from the current level of 41.23%. The

Mr Kanan succeeds Karen Miller who was recently promoted to vice president of strategy and corporate development. Mr Kanan will report to Rakesh Sachdev, vice president and CFO.

In this role, Dr George will be responsible for managing external relationships with cancer agencies, organizations and specialists around the world. Most recently, Dr George held the position

Kai Pharmaceuticals, a drug discovery and development company, has initiated a third Phase IIa study of KAI-1678, an isozyme-selective, small peptide inhibitor of the epsilon protein kinase C

Ondine Biopharma, a biotechnology company, has entered into a non-binding letter of intent with JS Dental Technologies, a Toronto-based firm to purchase the company’s dental healthcare business. Subject

Arbor Vita, a biopharmaceutical company, has received 510(k) clearance from the FDA for its AVantage A/H5N1 flu test. According to Arbor Vita, AVantage flu test is a non-invasive

Eric Poma, CEO of Molecular Templates, said: “Cancer therapeutics is a crowded and competitive field. Molecular Templates’s platform technology is compelling because it allows us to rapidly screen

Maynard Howe, vice chairman and CEO of Stemedica, said: “Stemedica is executing a dual-path strategy in which the Stemedica USA facility will continue to manufacture current good manufacturing